BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, announced today that the Company has entered into a policy roundtable with German regulators to legalize adult-use cannabis in the US brought Germany to life. At that meeting, German Drugs Commissioner Burkhard Blienert presented the plan to legalize cannabis for adults and reiterated the government’s announcement that a first draft of the bill would be presented in the coming months. With this event, Tilray reaffirms its leadership role as a trusted partner to government regulators and contributes to Germany’s legalization efforts by sharing its many years of expertise and experience in cannabis research, product quality and safety, supply management, patient and consumer protection, and cannabis education.

The meeting included leading figures from the German health and legal committees, including:

• Burkhard Blienert, Narcotics Commissioner at the Federal Ministry of Health
• Kristine Lütke, Member of the Bundestag (FDP), Drug Policy Spokesperson
• Carlos Kasper, MdB (SPD), finance committee
• Martina Stamm-Fibich, MdB (SPD), Health Committee

Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, Inc., said: “We are honored to have initiated this high-level exchange about one of the world’s most important cannabis companies. As a leading global cannabis company, Tilray Brands has unmatched experience working with governments and regulators to help develop responsible cannabis regulations that protect the health and safety of patients and consumers, and to support significant economic growth in the countries in which it operates. We applaud the German government for pioneering responsible adult cannabis legislation in Europe and are proud to support this effort.”

Sascha Mielcarek, Managing Director …